
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $2.08 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 17.44%, resulting in a loss of $14.32 million. Jaguar Health collected $630.00 thousand in revenue during Q3, but reported earnings showed a $12.19 million loss.